c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
EyePoint Pharmaceuticals (EYPT) Halts Wet AMD Program After Phase III Setback, Shifts Focus to DME
GuruFocus | Nov 12, 2026 12:56 PM EST
Related Stocks: EYPT ,
Read original article